Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study
出版年份 2023 全文链接
标题
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study
作者
关键词
-
出版物
CEPHALALGIA
Volume 43, Issue 4, Pages 033310242311605
出版商
SAGE Publications
发表日期
2023-03-15
DOI
10.1177/03331024231160519
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score
- (2022) Luigi Francesco Iannone et al. CNS DRUGS
- Predictors of sustained response and effects of the discontinuation of anti‐calcitonin gene related peptide antibodies and reinitiation in resistant chronic migraine
- (2022) Luigi Francesco Iannone et al. EUROPEAN JOURNAL OF NEUROLOGY
- 059 Switching CGRP monoclonal antibodies for chronic migraine: real-world outcomes of 37 episodes
- (2022) Mark Weatherall et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions
- (2022) Linda Al-Hassany et al. LANCET NEUROLOGY
- European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
- (2022) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy : The multicenter prospective cohort GARLIT study
- (2022) Fabrizio Vernieri et al. EUROPEAN JOURNAL OF NEUROLOGY
- Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial
- (2022) Roberto De Icco et al. JOURNAL OF HEADACHE AND PAIN
- Early outcomes of migraine after erenumab discontinuation: data from a real-life setting
- (2021) Eleonora De Matteis et al. NEUROLOGICAL SCIENCES
- Migraine therapeutics differentially modulate the CGRP pathway
- (2021) Minoti Bhakta et al. CEPHALALGIA
- Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment – a real-life cohort study
- (2021) Andreas R Gantenbein et al. CEPHALALGIA
- Early Experiences in Switching between Monoclonal Antibodies in Patients with Nonresponsive Migraine in Spain: A Case Series
- (2021) Ignacio Patier Ruiz et al. EUROPEAN NEUROLOGY
- The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice
- (2021) Jessica Ailani et al. HEADACHE
- Diagnosis and management of migraine in ten steps
- (2021) Anna K. Eigenbrodt et al. Nature Reviews Neurology
- Monoclonal Antibodies Targeting CGRP: From Clinical Studies to Real-World Evidence—What Do We Know So Far?
- (2021) Theodoros Mavridis et al. Pharmaceuticals
- Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study
- (2021) Bianca Raffaelli et al. CEPHALALGIA
- Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort study
- (2021) Lucas Hendrik Overeem et al. CEPHALALGIA
- In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study
- (2021) Alicia Alpuente et al. JOURNAL OF HEADACHE AND PAIN
- Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study
- (2021) Fabrizio Vernieri et al. JOURNAL OF HEADACHE AND PAIN
- European headache federation consensus on the definition of resistant and refractory migraine
- (2020) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Non‐Responders to Treatment With Antibodies to the CGRP‐Receptor May Profit From a Switch of Antibody Class
- (2019) Christian Ziegeler et al. HEADACHE
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Comparative efficacy of triptans for the abortive treatment of migraine: A multiple treatment comparison meta-analysis
- (2013) Kristian Thorlund et al. CEPHALALGIA
- The Importance of Placebo in Headache Research
- (2008) H-C Diener et al. CEPHALALGIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now